Selective Androgen Receptor Modulator (SARM)
Dragon Pharma LGD 4033 15 mg delivers a high-potency dose of Ligandrol, one of the most well-researched and effective Selective Androgen Receptor Modulators (SARMs) available. Unlike traditional anabolic steroids that activate androgen receptors throughout the body, LGD-4033 exhibits a strong selectivity for muscle and bone tissue. This targeted mechanism allows it to promote significant increases in lean muscle mass, strength, and endurance while minimizing androgenic side effects such as hair loss, acne, and prostate enlargement that are common with steroids.
Originally developed to treat muscle-wasting conditions, LGD-4033 has gained immense popularity in the fitness world for its ability to produce "steroid-like" gains in a cleaner, more manageable profile. Dragon Pharma's 15 mg tablet formulation is designed for users seeking substantial results, offering a balance between efficacy and tolerability. It works by binding powerfully to androgen receptors in skeletal muscle, stimulating protein synthesis and nitrogen retention. Users typically report noticeable improvements in muscle fullness, training performance, and recovery within 2-3 weeks. While often considered a "safer" alternative to steroids due to its tissue selectivity, LGD-4033 is still suppressive to natural testosterone production and requires responsible use, including Post Cycle Therapy (PCT) to ensure full hormonal recovery.
Key Benefits:
Each sachet contains 100 tablets of 15 mg Ligandrol (LGD-4033), manufactured under strict quality control standards in Dragon Pharma's certified facilities.
| Product Name | LGD 4033 15 mg |
| Manufacturer | Dragon Pharma |
| Substance | Ligandrol (LGD-4033) |
| Packaging | 100 Tablets / Sachet |
| Lab Test Result | 15.66 mg (Exceeds label claim) |
| Half-Life | ~24-36 hours |
| Recommended Cycle | 8-10 weeks |
| Form | Oral Tablet |
| Aromatization | No (Does not convert to estrogen) |
| Dosage (Men) | 5 mg - 15 mg per day |
Important Note: LGD-4033 is suppressive to natural testosterone production. While side effects are milder than steroids, Post Cycle Therapy (PCT) is still recommended after cycles, especially at doses of 10 mg+ per day. It is not hepatotoxic in the same way as oral steroids, but liver enzymes should still be monitored.
Despite being a SARM, LGD-4033 suppresses the HPTA. PCT helps restore natural hormone levels.
LGD-4033 is not C17-alpha alkylated, so liver stress is not a primary concern, but overall health support is advised.
These independent lab reports verify Dragon Pharma's commitment to potency and purity. The latest batch (2025) shows an overfill to 15.66 mg, guaranteeing you receive a full, potent dose with every tablet. Consistent testing ensures product reliability.
To maintain the stability and efficacy of LGD 4033 tablets:
No, it does not raise natural testosterone levels. In fact, LGD-4033 suppresses the body's natural testosterone production because it signals the hypothalamus and pituitary gland that there are sufficient androgens present (negative feedback loop). This is why testosterone levels often drop during an LGD cycle, leading to potential side effects like low libido and lethargy, especially at higher doses. This suppression is why Post Cycle Therapy (PCT) is recommended to help restart natural production.
LGD-4033 is primarily used by athletes and bodybuilders for two main purposes: Bulking/Gaining Lean Mass: It is highly effective at promoting significant increases in muscle size and strength with minimal water retention. Recomposition/Cutting: It helps preserve or even build lean muscle tissue while in a calorie deficit, making it ideal for fat loss phases. Medically, it was investigated for treating muscle wasting and osteoporosis due to its anabolic effects on muscle and bone.
Ligandrol has a relatively long half-life of approximately 24-36 hours. This means it stays active in the body for an extended period, allowing for convenient once-daily dosing. In terms of detection, metabolites may be detectable in urine for several weeks after the last dose, depending on the sensitivity of the test, dosage, and individual metabolism. It is banned by WADA and most sports organizations.
No, LGD-4033 is not hepatotoxic in the same way as C17-alpha alkylated oral steroids. It does not possess the same chemical modification that causes severe liver stress. However, it can still cause mild, transient elevations in liver enzymes in some individuals, likely due to the metabolic processing of the compound. While dedicated liver support (TUDCA) is not mandatory as with steroids, general liver health supplements (NAC) and monitoring are still prudent.
Yes, women can use LGD-4033, but with caution. Due to its high selectivity and low androgenic rating, the risk of virilization (masculinizing side effects) is much lower than with steroids. However, it is not zero. Women should start with a very low dose (e.g., 2.5 mg per day) for a short cycle (4-6 weeks) to assess tolerance. Any signs of voice changes or increased body hair should prompt immediate discontinuation.